Mohamad Mohty to Bortezomib
This is a "connection" page, showing publications Mohamad Mohty has written about Bortezomib.
Connection Strength
0.216
-
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study. Clin Lymphoma Myeloma Leuk. 2018 10; 18(10):e401-e419.
Score: 0.173
-
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma. Blood. 2018 12 06; 132(23):2456-2464.
Score: 0.044